Precigen reports Q4 EPS (11c), consensus (10c)

Total revenues decreased $1.9M, or 52%, from the three months ended December 31, 2021. Product and service revenues generated by Exemplar decreased $1.8M from the three months ended December 31, 2021. Gross margin on product and services decreased comparable to the prior year due to the reduction in revenues and increased costs for supplies, drugs, and personnel at Exemplar. Q4 revenue consensus $6.21M.